-
KV Pharmaceuticals lists price of newly-FDA approved pre-term labor drug Makena at $1,500 per dose. Compounders had been making the drug for as little as $10 per dose.
-
The FDA announced that it will not take action against companies making compounded versions of pre-term labor drug Makena. This move was meant to keep the drug affordable following the price spike.
-
Bowing to pressure from the medical community and the FDA, KV Pharmaceuticals cuts the price of Makena pre-term labor drug in half to $690 per dose from $1,500 per dose.
-
KV Pharmaceuticals files for Chapter 11 Bankruptcy following the Makena pricing debate.
-
3 doctors, all affiliatd with Memorial Sloan-Kettering Cancer Center, wrote a scathing review of the price of Sanofi's Zaltrap cancer drug. Thy lamented the high price and announced that the center would not provide the drug--opting instead to provide lower-cost Avastin.
-
Following the New York Times piece and other instances of public outcry Sanofi savd an offered Zaltrap at a 50% discount. The durg was still more expensive than competitor Avastin.
-
After Valeant bought heart medications Isuprel and Nitropress from Marathon Pharmaceuticals, it increased their prices by about 525% and 212%.
-
HHS’ Office of Inspector General announces it will investigate skyrocketing drug prices, including the jump from $20 for a 500-count bottle of 100 mg doxycycline tablets to $1849.
-
Turing Pharmaceuticals acquires the exclusive marketing rights to Daraprim from Impax Laboratories.
-
Senator Bernie Sanders (I-VT) tweeted: “It is unacceptable that Americans pay, by far, the highest prices in the world for prescription drugs.”
-
Senator Bernie Sanders (I-Vt), rolled out his drug pricing bill, the Prescription Drug Affordability Act of 2015. Sanders is calling to give Medicare the ability to bargain on drug prices and the bill also would allow US residents to import lower-cost medications from Canada.
-
Senator Bernie Sanders and Representative Elijah Cummings sent a joint letter to Valeant Pharmaceuticals requesting information related to the price hike of two key heart drugs, Nitropress and Isuprel.
-
Presidential hopeful Hillary Clinton tweets: “Price gouging like this in the specialty drug market is outrageous. Tomorrow I’ll lay out a plan to take it on.”
-
Rodelis announces Monday that it was returning the drug to the Chao Center, following the media frenzy over the Daraprim price increase. The drug will still cost $1050 for 30 capsules, which is double the original price, but far below Rodelis’ initial cost hike.
-
Turing CEO backpedals and announces that the price of daraprim will not be $750 per pill. The company does not say what the new price will be.
-
Hillary Clinton proposed, among other things, a $250-per-month cap on out-of-pocket costs for those with chronic conditions, said Medicare should be able to negotiate drug prices, and discussed allowing Americans to buy some drugs from Europe.
